Asia Pacific Osteoarthritis Therapeutics Market Size & Outlook
Related Markets
Asia Pacific osteoarthritis therapeutics market highlights
- The Asia Pacific osteoarthritis therapeutics market generated a revenue of USD 1,043.8 million in 2025.
- The market is expected to grow at a CAGR of 9.2% from 2026 to 2033.
- In terms of segment, viscosupplements was the largest revenue generating product in 2025.
- Other (Cartilage Resurfacing Products) is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 1,043.8 million |
| Market revenue in 2033 | USD 2,130.2 million |
| Growth rate | 9.2% (CAGR from 2026 to 2033) |
| Largest segment | Viscosupplements |
| Fastest growing segment | Other (Cartilage Resurfacing Products) |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Platelet-Rich Plasma (PRP) Therapy, Autologous Chondrocyte Implantation (ACI), Including MACI, Adipose Tissue Therapy, BMAC (Bone Marrow Aspirate Concentrate) Therapy, Stem Cell (other), Bone Graft Substitutes, Viscosupplements, Other (Cartilage Resurfacing Products) |
| Key market players worldwide | GlaxoSmithKline Consumer Healthcare (GSK CH India), Sanofi SA, Pfizer Inc, Bayer AG, Zimmer Biomet Holdings Inc, Novartis AG ADR, Anika Therapeutics Inc, Assertio Holdings Inc, Bioventus Inc Class A |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.0% of the global osteoarthritis therapeutics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,130.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Osteoarthritis Therapeutics Market Scope
Osteoarthritis Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Assertio Holdings Inc | View profile | 30 | 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 | https://www.assertiotx.com |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| Bioventus Inc Class A | View profile | 995 | 4721 Emperor Boulevard, Suite 100, Durham, NC, United States, 27703 | https://www.bioventus.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Asia Pacific osteoarthritis therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis therapeutics market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 53.01% in 2025. Horizon Databook has segmented the Asia Pacific osteoarthritis therapeutics market based on platelet-rich plasma (prp) therapy, autologous chondrocyte implantation (aci), including maci, adipose tissue therapy, bmac (bone marrow aspirate concentrate) therapy, stem cell (other), bone graft substitutes, viscosupplements, other (cartilage resurfacing products) covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Asia Pacific osteoarthritis therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific osteoarthritis therapeutics market databook
-
Our clientele includes a mix of osteoarthritis therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific osteoarthritis therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific osteoarthritis therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific osteoarthritis therapeutics market size, by country, 2021-2033 (US$M)
Asia Pacific Osteoarthritis Therapeutics Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
